BIOXCEL THERAPEUTICS INC. - COMMON STOCK

BioXcel Therapeutics to Ring Nasdaq Stock Market Closing Bell Today

21 2 2023 07:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics Announces Positive Full Data from Phase 2 Trial of BXCL701 in Rare, Aggressive Form of Prostate Cancer; to be Presented at 2023 ASCO Genitourinary Cancers Symposium

13 2 2023 17:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics to Host BXCL701 Key Opinion Leader Day to Highlight Company’s Investigational, Oral Innate Immune Activator for Rare Form of Prostate Cancer

08 2 2023 07:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics Announces Promising Top-Line Results from Phase 2 Trial of BXCL701 in Aggressive Form of Rare Prostate Cancer

11 1 2023 07:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference

22 12 2022 07:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics Announces First Patient Dosed in TRANQUILITY III Phase 3 Trial for Acute Treatment of Agitation in Patients with Alzheimer’s Disease

19 12 2022 07:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics to Present at Bank of America 2022 Biotech SMID Cap Conference

01 12 2022 07:00:01 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics Announces First Patients Dosed in SERENITY III Phase 3 Trial for Acute Treatment of Agitation in Adults with Bipolar I or II Disorder or Schizophrenia

30 11 2022 07:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics to Present at Two Upcoming Investor Conferences

14 11 2022 07:00:02 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Operational Highlights

10 11 2022 07:00:04 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics to Report Third Quarter 2022 Financial Results on November 10, 2022

27 10 2022 07:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics to Host IGALMI™ Commercial Day on October 18, 2022

05 10 2022 07:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics to Participate at the H.C. Wainwright 24th Annual Global Investment Conference

07 9 2022 07:00:01 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights

09 8 2022 07:00:01 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics to Participate at the Canaccord Genuity 42nd Annual Growth Conference

03 8 2022 07:00:01 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022

26 7 2022 07:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics Appoints Michael P. Miller to Board of Directors

05 7 2022 07:00:01 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics to Participate at Two Upcoming Investor Conferences

07 6 2022 07:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics Announces Updated Presentation Time at H.C. Wainwright Global Investment Conference

20 5 2022 07:00:00 提供 Nasdaq GlobeNewswire

BioXcel Therapeutics Reports First Quarter 2022 Financial Results and Recent Operational Highlights

09 5 2022 07:00:01 提供 Nasdaq GlobeNewswire